(Q45148148)

English

Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 December 2017

Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial (English)

1 reference

Europe PubMed Central

10 December 2017

author name string

Ortonne JP

1

1 reference

Europe PubMed Central

10 December 2017

Kaufmann R

2

1 reference

Europe PubMed Central

10 December 2017

Lecha M

3

1 reference

Europe PubMed Central

10 December 2017

Goodfield M

4

1 reference

Europe PubMed Central

10 December 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

10 December 2017

1 reference

Europe PubMed Central

10 December 2017

209

1 reference

Europe PubMed Central

10 December 2017

4

1 reference

Europe PubMed Central

10 December 2017

308-313

1 reference

Europe PubMed Central

10 December 2017

Psoriasis--epidemiology and clinical spectrum

1 reference

https://api.crossref.org/works/10.1159%2F000080854

21 January 2018

Treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1159%2F000080854

21 January 2018

Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical tria

1 reference

https://api.crossref.org/works/10.1159%2F000080854

21 January 2018

A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1159%2F000080854

21 January 2018

Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1159%2F000080854

21 January 2018

A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1159%2F000080854

21 January 2018

Identifiers

10.1159/000080854

1 reference

Europe PubMed Central

10 December 2017

1 reference

Europe PubMed Central

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45148148&oldid=2067037877"